Benefits of cardiac surgery in octogenarians--a postoperative quality of life assessment.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 17369044)

Published in Eur J Cardiothorac Surg on March 19, 2007

Authors

Christoph H Huber1, Volkhard Goeber, Pascal Berdat, Thierry Carrel, Friedrich Eckstein

Author Affiliations

1: Division of Cardiovascular Surgery, University Hospital of Lausanne, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland. Christoph.Huber@hospvd.ch

Articles citing this

Cardiac surgery in the elderly patient. Dtsch Arztebl Int (2009) 1.24

Risk profile and outcomes of aortic valve replacement in octogenarians. World J Cardiol (2011) 0.89

Quality-of-Life measures for cardiac surgery practice and research: a review and primer. J Extra Corpor Technol (2013) 0.85

Prolonged intensive care treatment of octogenarians after cardiac surgery: a reasonable economic burden? Interact Cardiovasc Thorac Surg (2013) 0.84

Advanced age and the clinical outcomes of transcatheter aortic valve implantation. J Geriatr Cardiol (2014) 0.81

Early and late outcomes after isolated aortic valve replacement in octogenarians: an Australasian Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database Study. Eur J Cardiothorac Surg (2012) 0.81

Combined cardiac surgical procedures in octogenarians: operative outcome. Clin Res Cardiol (2008) 0.81

Does coronary artery bypass grafting improve quality of life in elderly patients? Interact Cardiovasc Thorac Surg (2013) 0.81

Emerging approaches of transcatheter valve repair/insertion. Cardiol Res Pract (2010) 0.78

Health-related quality of life after cardiac surgery--the effects of age, preoperative conditions and postoperative complications. J Cardiothorac Surg (2014) 0.78

Does quality of life improve in octogenarians following cardiac surgery? A systematic review. BMJ Open (2015) 0.77

What do the recent American Heart Association/American College of Cardiology Foundation Clinical Practice Guidelines tell us about the evolving management of coronary heart disease in older adults? J Geriatr Cardiol (2013) 0.76

Cardiac anesthesia and surgery in geriatric patients: epidemiology, current surgical outcomes, and future directions. HSR Proc Intensive Care Cardiovasc Anesth (2009) 0.75

Patient and spouse perceived quality of life five years after coronary artery bypass graft surgery. Open Nurs J (2008) 0.75

Video-Assisted Thoracoscopic Surgery for Treatment of Chronic Obstructive Pulmonary Disease. Indian J Surg (2015) 0.75

Articles by these authors

Transformation of percutaneous venoarterial extracorporeal membrane oxygenation access to a safe peripheral arterial cannulation. J Thorac Cardiovasc Surg (2013) 3.24

Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial. Crit Care Med (2009) 2.47

Off-pump pulmonary valve replacement with the new Shelhigh Injectable Stented Pulmonic Valve. J Thorac Cardiovasc Surg (2006) 2.01

Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves. JACC Cardiovasc Interv (2011) 1.94

Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality. J Am Coll Cardiol (2011) 1.86

Surgery for complications of trans-catheter closure of atrial septal defects: a multi-institutional study from the European Congenital Heart Surgeons Association. Eur J Cardiothorac Surg (2010) 1.86

Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation. JACC Cardiovasc Interv (2012) 1.84

Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol (2010) 1.71

Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J (2013) 1.70

S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes. J Am Coll Cardiol (2011) 1.68

Scimitar syndrome: a European Congenital Heart Surgeons Association (ECHSA) multicentric study. Circulation (2010) 1.59

Quality of life of grown-up congenital heart disease patients after congenital cardiac surgery. Eur J Cardiothorac Surg (2009) 1.56

Mortality and neurologic injury after surgical repair with hypothermic circulatory arrest in acute and chronic proximal thoracic aortic pathology: effect of age on outcome. Circulation (2011) 1.56

Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg (2004) 1.54

The location of the primary entry tear in acute type B aortic dissection affects early outcome. Eur J Cardiothorac Surg (2012) 1.48

Aortitis following percutaneous aortic side branch embolization prior to endovascular repair of infrarenal aortic aneurysm. J Endovasc Ther (2007) 1.46

Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol (2012) 1.44

Effect on false-lumen status of a combined vascular and endovascular approach for the treatment of acute type A aortic dissection. Eur J Cardiothorac Surg (2011) 1.43

Type A aortic dissection after nonaortic cardiac surgery. Circulation (2013) 1.40

Should aortic arch replacement be performed during initial surgery for aortic root aneurysm in patients with Marfan syndrome? Eur J Cardiothorac Surg (2013) 1.40

Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders. Hum Mutat (2006) 1.40

A novel blood-sparing agent in cardiac surgery? First in-patient experience with the synthetic serine protease inhibitor MDCO-2010: a phase II, randomized, double-blind, placebo-controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Anesth Analg (2014) 1.38

Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thorac Cardiovasc Surg (2008) 1.35

Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant (2009) 1.34

Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Eur Heart J (2012) 1.33

Self-made pericardial tube graft: a new surgical concept for treatment of graft infections after thoracic and abdominal aortic procedures. Ann Thorac Surg (2011) 1.33

Mechanisms of failure and outcome of secondary surgical interventions after thoracic endovascular aortic repair (TEVAR). Ann Thorac Surg (2011) 1.24

Iatrogenic left main coronary artery dissection: incidence, classification, management, and long-term follow-up. Am Heart J (2010) 1.23

Massive pulmonary embolism: surgical embolectomy versus thrombolytic therapy--should surgical indications be revisited? Eur J Cardiothorac Surg (2012) 1.22

Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention (2011) 1.22

Complications associated with the arterial puncture closure device--Angio-Seal. Vasc Endovascular Surg (2008) 1.22

Percutaneous management of vascular complications in patients undergoing transcatheter aortic valve implantation. JACC Cardiovasc Interv (2012) 1.19

Excellent outcome after surgical treatment of massive pulmonary embolism in critically ill patients. J Thorac Cardiovasc Surg (2008) 1.17

Plicated patch repair for acquired Gerbode defect involving the tricuspid valve. Ann Thorac Surg (2010) 1.13

Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis. Eur J Cardiothorac Surg (2011) 1.12

Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J (2011) 1.12

Acute aortic dissection determines the fate of initially untreated aortic segments in Marfan syndrome. Circulation (2013) 1.09

Editorial comment: Selective sinus repair in acute type A dissection. Eur J Cardiothorac Surg (2013) 1.08

Adverse mid-term outcome following RVOT reconstruction using the Contegra valved bovine jugular vein. Ann Thorac Surg (2005) 1.07

Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome. Hum Genet (2007) 1.07

Procedural factors associated with early postoperative arrhythmias after repair of congenital heart defects. J Thorac Cardiovasc Surg (2002) 1.02

Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms. Circulation (2009) 1.01

Predictors of clinical outcomes in patients with severe aortic stenosis undergoing TAVI: a multistate analysis. Circ Cardiovasc Interv (2012) 1.01

Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure. J Thorac Cardiovasc Surg (2006) 0.98

Clinical experience with the second-generation 3f Enable sutureless aortic valve prosthesis. J Thorac Cardiovasc Surg (2010) 0.96

Elimination of proinflammatory cytokines in pediatric cardiac surgery: analysis of ultrafiltration method and filter type. J Thorac Cardiovasc Surg (2004) 0.95

Important excess morbidity due to upper airway anomalies in the perioperative course in infant cardiac surgery. Ann Thorac Surg (2006) 0.95

Contractile function is preserved in unloaded hearts despite atrophic remodeling. J Thorac Cardiovasc Surg (2009) 0.94

Plasma levels of interleukin-8 and expression of interleukin-8 receptors on circulating neutrophils and monocytes after cardiopulmonary bypass in children. J Thorac Cardiovasc Surg (2003) 0.94

Current state of the art in myocardial tissue engineering. Tissue Eng (2007) 0.94

Students' knowledge of symptoms and risk factors of potential life-threatening medical conditions. Swiss Med Wkly (2010) 0.94

Atrioventricular conduction after transcatheter aortic valve implantation and surgical aortic valve replacement. J Cardiovasc Electrophysiol (2012) 0.93

Transcatheter aortic valve implantation or surgical aortic valve replacement as redo procedure after prior coronary artery bypass grafting. Ann Thorac Surg (2011) 0.93

What makes the difference between the natural course of a remaining type B dissection after type A repair and a primary type B aortic dissection? Eur J Cardiothorac Surg (2012) 0.92

Quantitative sequence analysis of FBN1 premature termination codons provides evidence for incomplete NMD in leukocytes. Hum Mutat (2009) 0.92

Papillary fibroelastoma of the heart. Heart Surg Forum (2008) 0.92

The Sorin Freedom SOLO stentless aortic valve: technique of implantation and operative results in 109 patients. J Thorac Cardiovasc Surg (2009) 0.91

No risk of surgical site infections from residual bacteria after disinfection with povidone-iodine-alcohol in 1014 cases: a prospective observational study. Ann Surg (2012) 0.91

Congenital tuberculosis in a premature infant. Swiss Med Wkly (2002) 0.91

A comparison of patient characteristics and 30-day mortality outcomes after transcatheter aortic valve implantation and surgical aortic valve replacement for the treatment of aortic stenosis: a two-centre study. EuroIntervention (2009) 0.91

The arterial switch operation in Europe for transposition of the great arteries: a multi-institutional study from the European Congenital Heart Surgeons Association. J Thorac Cardiovasc Surg (2006) 0.90

Proteomic alterations in heat shock protein 27 and identification of phosphoproteins in ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve. J Mol Cell Cardiol (2007) 0.90

Arterial access through the right subclavian artery in surgery of the aortic arch improves neurologic outcome and mid-term quality of life. Ann Thorac Surg (2008) 0.90

Reoperations and late adverse outcome in Marfan patients following cardiovascular surgery. Eur J Cardiothorac Surg (2004) 0.89

Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. Eur J Cardiothorac Surg (2011) 0.88

Proteomics in cardiovascular surgery. J Thorac Cardiovasc Surg (2007) 0.88

Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement. Eur J Cardiothorac Surg (2012) 0.88

Thyronin treatment in adult and pediatric heart surgery: clinical experience and review of the literature. Eur J Heart Fail (2002) 0.87

Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair. Artif Organs (2007) 0.87

Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiency. Eur J Hum Genet (2010) 0.87

Reoperations in adults with congenital heart disease: analysis of early outcome. Int J Cardiol (2004) 0.87

Early postoperative arrhythmias after open-heart procedures in children with congenital heart disease. Pediatr Crit Care Med (2001) 0.87

Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry. EuroIntervention (2014) 0.86

An uncommon cause of coronary artery ostial obstruction: papillary fibroelastoma. Echocardiography (2010) 0.85

The bovine jugular vein: a totally integrated valved conduit to repair the right ventricular outflow. J Heart Valve Dis (2002) 0.85

Antegrade selective cerebral perfusion and moderate hypothermia in aortic arch surgery: clinical outcomes in elderly patients. Eur J Cardiothorac Surg (2012) 0.85

Closure of apical access site after transapical, transcatheter paravalvular leak closure. Can J Cardiol (2012) 0.85

Surgery of the dilated aortic root and ascending aorta in pediatric patients: techniques and results. Eur J Cardiothorac Surg (2003) 0.84

The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis. EuroIntervention (2012) 0.83

PLTs of blood group A1 donors express increased surface A antigen owing to apheresis and prolonged storage. Transfusion (2003) 0.83

Clinical outcome of high-risk patients with severe aortic stenosis and reduced left ventricular ejection fraction undergoing medical treatment or TAVI. PLoS One (2011) 0.83

Histo-blood group antigens as allo- and autoantigens. Ann N Y Acad Sci (2005) 0.83

Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device. EuroIntervention (2014) 0.83

Acute device-based blood pressure reduction: electrical activation of the carotid baroreflex in patients undergoing elective carotid surgery. Vascular (2007) 0.82

Huge aneurysm of the ascending aorta in a patient with adult-type Pompe's disease: histological findings mimicking fibrillinopathy. Eur J Cardiothorac Surg (2012) 0.82

Prenatal diagnosis and treatment planning of congenital heart defects-possibilities and limits. World J Pediatr (2009) 0.82

CYP3A5*3 and POR*28 genetic variants influence the required dose of tacrolimus in heart transplant recipients. Ther Drug Monit (2014) 0.82

Transfusion of allogeneic blood products in proximal aortic surgery with hypothermic circulatory arrest: effect of thromboelastometry-guided transfusion management. J Cardiothorac Vasc Anesth (2013) 0.82

Age-dependent suppression of SERCA2a mRNA in pediatric atrial myocardium. Biochem Biophys Res Commun (2005) 0.81

The role of contrast-enhanced spiral CT imaging versus chest X-rays in surgical therapeutic concepts and thoracic aortic injury: a 29-year Swiss retrospective analysis of aortic surgery. Cardiovasc J S Afr (2005) 0.81

Ideal site for ventricular anchoring of artificial chordae in mitral regurgitation. J Thorac Cardiovasc Surg (2011) 0.81